Ceftriaxone Sodium Market Revenue 2024 to 2034
Ceftriaxone Sodium Market Revenue 2024 to 2034
The ceftriaxone sodium market, worth USD 1.45 billion in 2024, is expected to hit USD 2.12 billion by 2034, growing at a 3.9% CAGR, fueled by broad-spectrum antibiotic applications.
Report ID: 10456
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 1.45 Bn
Forecast Year,
USD 2.13 Bn
CAGR, 2025 -
3.90%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Ceftriaxone Sodium Market Size Analysis
Ceftriaxone Sodium Market Size By Form 2024 to 2034 (USD )
| Form | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Powder | 0.13 | 0.13 | 0.09 | 0.09 | 0.14 | 0.14 | 0.17 | 0.22 | 0.27 | 0.30 | 0.34 |
| Injection | 0.60 | 0.61 | 0.64 | 0.64 | 0.68 | 0.75 | 0.80 | 0.84 | 0.87 | 0.92 | 0.95 |
| Other | 0.72 | 0.76 | 0.83 | 0.89 | 0.87 | 0.87 | 0.85 | 0.84 | 0.83 | 0.83 | 0.84 |
Ceftriaxone Sodium Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory | 0.47 | 0.47 | 0.49 | 0.51 | 0.52 | 0.57 | 0.58 | 0.56 | 0.60 | 0.62 | 0.65 |
| Urinary Tract | 0.37 | 0.38 | 0.38 | 0.47 | 0.51 | 0.50 | 0.51 | 0.51 | 0.50 | 0.59 | 0.59 |
| Skin Infections | 0.17 | 0.17 | 0.17 | 0.13 | 0.16 | 0.18 | 0.14 | 0.15 | 0.10 | 0.04 | 0.02 |
| Other | 0.43 | 0.48 | 0.53 | 0.52 | 0.50 | 0.51 | 0.60 | 0.67 | 0.76 | 0.79 | 0.87 |
Ceftriaxone Sodium Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 0.23 | 0.21 | 0.23 | 0.20 | 0.21 | 0.21 | 0.20 | 0.15 | 0.19 | 0.19 | 0.17 |
| Clinics | 0.44 | 0.46 | 0.43 | 0.45 | 0.47 | 0.51 | 0.55 | 0.60 | 0.59 | 0.59 | 0.64 |
| Retail Pharmacies | 0.35 | 0.39 | 0.44 | 0.45 | 0.45 | 0.50 | 0.52 | 0.51 | 0.54 | 0.58 | 0.56 |
| Others | 0.42 | 0.45 | 0.46 | 0.52 | 0.56 | 0.54 | 0.55 | 0.63 | 0.65 | 0.68 | 0.75 |
Ceftriaxone Sodium Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.12 | 0.14 | 0.16 | 0.17 | 0.17 | 0.16 | 0.18 | 0.11 | 0.12 | 0.14 | 0.16 |
| Europe | 0.46 | 0.49 | 0.51 | 0.55 | 0.55 | 0.59 | 0.64 | 0.66 | 0.67 | 0.72 | 0.74 |
| Asia Pacific | 0.33 | 0.33 | 0.32 | 0.37 | 0.40 | 0.33 | 0.37 | 0.36 | 0.44 | 0.39 | 0.43 |
| Latin America | 0.48 | 0.47 | 0.45 | 0.43 | 0.44 | 0.50 | 0.51 | 0.60 | 0.59 | 0.59 | 0.59 |
| Middle East & Africa | 0.07 | 0.08 | 0.12 | 0.12 | 0.14 | 0.18 | 0.13 | 0.16 | 0.15 | 0.21 | 0.19 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
